1. Home
  2. BLLN vs HRI Comparison

BLLN vs HRI Comparison

Compare BLLN & HRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$96.06

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Logo Herc Holdings Inc.

HRI

Herc Holdings Inc.

HOLD

Current Price

$136.68

Market Cap

4.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
HRI
Founded
2016
1965
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Misc Corporate Leasing Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.3B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
BLLN
HRI
Price
$96.06
$136.68
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$126.71
$162.33
AVG Volume (30 Days)
771.8K
410.4K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
2.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,376,000,000.00
Revenue This Year
$46.29
$10.12
Revenue Next Year
$30.14
$6.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.65
52 Week Low
$61.96
$88.45
52 Week High
$138.70
$188.35

Technical Indicators

Market Signals
Indicator
BLLN
HRI
Relative Strength Index (RSI) 55.60 54.25
Support Level $79.07 $128.12
Resistance Level $97.36 $142.04
Average True Range (ATR) 7.92 6.75
MACD 0.95 -0.58
Stochastic Oscillator 58.11 48.69

Price Performance

Historical Comparison
BLLN
HRI

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About HRI Herc Holdings Inc.

Herc Holdings is an equipment rental company that was spun out of Hertz Global in 2016. It is currently the third-largest player in North America, after United Rentals and Sunbelt Rentals, with an approximate 6% market share pro forma for its 2025 acquisition of H&E Equipment Services. It serves a similar mix of companies to its peers (industrial, commercial, and residential construction) from its 450 locations targeting the top 100 metropolitan markets in the US. Herc's rental fleet of approximately $7 billion is also similar in composition to its peer group in terms of equipment offered. The company is also pursuing diversification by bundling and increasing specialty solutions for its customer base. Herc's portfolio skews toward local customers versus national accounts (60%/40%).

Share on Social Networks: